Company registration number 32266355
Copenhagen, Denmark, June 7, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”), announces today the notice of the Annual General Meeting of the Company to be held on:
Wednesday, June 29, 2022, at 2:00 p.m. (CEST)
at the offices of Gorrissen Federspiel, Axeltorv 2, DK-1609 Copenhagen V.
Notice of Annual General Meeting, including Appendix 1: Nominees to the Board of Directors is attached.
Additional information on the Annual General Meeting is available on the Company’s website: https://orphazyme.gcs-web.com/annual-general-meeting-0
For more information, please contact
Anders Vadsholt, Managing Director and Chief Financial Officer: +45 28 98 90 55
This company announcement may contain certain forward-looking statements under the United States Private Securities Litigation Reform Act of 1995 and otherwise, including forward-looking statements regarding the company’s annual meeting, annual and interim reports and the timing of such meeting. -this. Although the Company believes that its expectations are based on reasonable assumptions, all statements other than statements of historical facts included in this Company announcement regarding future events are subject to (i) change without notice and (ii) factors beyond the Company’s control, including pursuant to regulatory or judicial intervention. Except as required by law, the Company undertakes no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.